Nice Human Immunodeficiency Virus (HIV) Cohort
ConditionHuman Immunodeficiency Virus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire de Nice
About this trial
Historically, the database on the HIV was organized within the framework of the medico-economic file of the human immunodeficiency (DMI-2), introduced jointly by the Direction of Hospitals (Mission AIDS) and the INSERM at the end of the 80s. Today this database is fed via the computerized medical record NADIS. Most part of the research works on the theme of the HIV take support on this database (DAD, EuroAIDS, Neuradapt).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Enrol consecutive patients with a scheduled visit in the outpatient clinic (regardless of CD4 cell count and ART status).
Disqualifiers
None
Trial population
Patients HIV innocents of any treatment and recently infected
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Follow up
Other interventionFollow up of treatment, behavior, co-morbidity
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
change of the clinico-biological signs of the patients
change of the clinico-biological values form the start of the study, mesured every year, to the end of the study
Time frame
Each Year during 50 yearsSecondary outcomes
1
number of the various type of adverse events related by type of treatments
Number of patients and laboratory data related to any events occurred such as : Death, Acute myocardial infarction , Ascites, Bone Mass Density , Diabetes mellitus, End Stage Renal Disease , Fibroscan stiffness , Bone fracture , Hepatic encephalopathy , Hepatorenal syndrome Invasive Cardiovascular Procedures , Kidney transplantation , Liver biopsy , Liver decompensation , Liver transplantation Non-AIDS defining malignancies , AIDS defining malignancies, Oesophageal variceal bleeding , Stroke
Time frame
Each Year during 50 yearsOther outcomes
1
number of the various type of co-morbidity
Number of death, immediate cause of death, underlying conditions of death, ongoing risk factors in the year prior of the death, descripion of co-moirbidities (ongoing chronic conditions, prior cardiovascular diseases, history of depression, history of psychosis, liver diseases)
Time frame
Each Year during 50 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov